Notably, our study has demonstrated markedly aberrant FOXJ1 localization and the down-regulation of FOXJ1 mRNA expression levels in patients with NPs who have co-existing AR or asthma, which strongly suggested that aberrant FOXJ1 localization might have contributed considerably to the greater disease severity in patients with NPs. Here, FOXJ1 is linked to asthma.